Elizabeth L. Siegler

发表

Nanomedicine targeting the tumor microenvironment: Therapeutic strategies to inhibit angiogenesis, remodel matrix, and modulate immune responses

Yu Jeong Kim, Pin Wang, Elizabeth L Siegler, 2016 .

Resistance to CART cell therapy: lessons learned from the treatment of hematological malignancies

Elizabeth L Siegler, R. Sakemura, Elizabeth L. Siegler, 2021, Leukemia & lymphoma.

Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies

Elizabeth L Siegler, Elizabeth L. Siegler, S. Kenderian, 2020, Frontiers in Immunology.

In vivo CART cell imaging: Paving the way for success in CART cell therapy

Elizabeth L Siegler, I. Can, R. Sakemura, 2021, Molecular therapy oncolytics.

CART Cell Toxicities: New Insight into Mechanisms and Management

Elizabeth L Siegler, Elizabeth L. Siegler, S. Kenderian, 2020, Clinical hematology international.

CAR-T Cells Surface-Engineered with Drug-Encapsulated Nanoparticles Can Ameliorate Intratumoral T-cell Hypofunction

Jennifer A. Rohrs, Yu Jeong Kim, Yarong Liu, 2018, Cancer Immunology Research.

Combination Cancer Therapy Using Chimeric Antigen Receptor-Engineered Natural Killer Cells as Drug Carriers.

Jennifer A. Rohrs, Natnaree Siriwon, Pin Wang, 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

Designed Ankyrin Repeat Proteins as Her2 Targeting Domains in Chimeric Antigen Receptor-Engineered T Cells.

Pin Wang, Elizabeth L Siegler, Elizabeth L. Siegler, 2017, Human gene therapy.

Who wins the combat, CAR or TCR?

Elizabeth L Siegler, Elizabeth L. Siegler, S. S. Kenderian, 2023, Leukemia.

CAR-T Cell Therapy: the Efficacy and Toxicity Balance

Elizabeth L Siegler, Elizabeth L. Siegler, E. Siegler, 2023, Current Hematologic Malignancy Reports.

CRISPR Takes the Front Seat in CART-Cell Development

Elizabeth L Siegler, Elizabeth L. Siegler, S. Kenderian, 2021, BioDrugs.

CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities

Elizabeth L Siegler, L. K. Kankeu Fonkoua, R. Sakemura, 2022, Molecular therapy oncolytics.

Evaluating CAR‐T Cell Therapy in a Hypoxic 3D Tumor Model

Keyue Shen, Yuta Ando, K. Shen, 2019, Advanced healthcare materials.

Leukemic Extracellular Vesicles Induce Chimeric Antigen Receptor T Cell Dysfunction in Chronic Lymphocytic Leukemia.

Yohan Kim, E. Braggio, N. Kay, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

Cancer Stem Cells : Impact on Treatment Therapeutic strategies for targeting cancer stem cells

Natnaree Siriwon, Pin Wang, Elizabeth L Siegler, 2016 .

Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity

Aditya Bansal, M. Pandey, T. DeGrado, 2021, Cancer Immunology Research.

Engineering CAR-expressing natural killer cells with cytokine signaling and synthetic switch for an off-the-shelf cell-based cancer immunotherapy

Pin Wang, Elizabeth L Siegler, Gunce E. Cinay, 2019, MRS Communications.

Off-the-Shelf CAR-NK Cells for Cancer Immunotherapy.

Lili Yang, Pin Wang, Elizabeth L Siegler, 2018, Cell stem cell.

Targeting Cancer-Associated Fibroblasts in the Bone Marrow Prevents Resistance to CART-Cell Therapy in Multiple Myeloma.

N. Kay, D. Jelinek, Yi Lin, 2022, Blood.

GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity

N. Kay, S. Sinha, M. Adada, 2022, Leukemia.

Optimized CART Cell Therapy for Metastatic Aggressive Thyroid Cancer

R. Smallridge, J. Copland, A. Zubair, 2024, bioRxiv.

Mesenchymal stromal cells with chimaeric antigen receptors for enhanced immunosuppression.

R. Sakemura, Elizabeth L. Siegler, M. Hefazi, 2024, Nature biomedical engineering.

Combination Therapeutics with CAR-T Cell Therapy

M. Adada, Elizabeth L Siegler, Elizabeth L. Siegler, 2022, Cancer Drug Discovery and Development.

Cell Stem Cell In Translation Off-the-ShelfCAR-NKCells forCancer Immunotherapy

Lili Yang, Pin Wang, Elizabeth L Siegler, 2018 .

Gene Editing and Gene Therapy: Entering Uncharted Territory in Veterinary Oncology

S. Ekker, J. Mochel, Wesley A. Wierson, 2021 .

Treatment strategies for relapse after CAR T-cell therapy in B cell lymphoma

R. Sakemura, Elizabeth L. Siegler, K. Miyao, 2024, Frontiers in pediatrics.

Abstract 5017: Simultaneous targeting of EphA3 on glioblastoma and tumor microenvironment to overcome resistance to CART cell therapy in brain cancer

R. Sakemura, Elizabeth L. Siegler, M. Hefazi, 2023, Cancer Research.

A Concise Review of Neurologic Complications Associated with Chimeric Antigen Receptor T-cell Immunotherapy.

Elizabeth L Siegler, Elizabeth L. Siegler, S. Kenderian, 2020, Neurologic clinics.

Preclinical Models in Chimeric Antigen Receptor-Engineered T-Cell Therapy.

Pin Wang, Elizabeth L Siegler, Elizabeth L. Siegler, 2018, Human gene therapy.